Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trials

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
H Bindu MusunuruAndrew Loblaw

Abstract

To compare biochemical outcome and toxicities of two prospective 5-fraction stereotactic ablative radiotherapy (SABR) studies in prostate cancer. 84 patients in pHART3 received 35 Gy, 30 patients in pHART6 received 40 Gy in 5-fractions to the prostate alone, once weekly. 4mm and 5mm PTV margins were used, respectively. Biochemical outcome, acute, late and cumulative genitourinary (GU)/gastrointestinal (GI) toxicities were compared. Median follow-up was 74 and 36 months, respectively. Median prostate specific antigen nadir was 0.4 ng/ml and 0.3 ng/ml. 2-, 4- and 6-year biochemical relapse-free survival (bRFS-2+nadir) was 100%, 98.7% and 95.9% in pHART3; 100%, 100% and not reached in pHART6 (p=0.91). There was one acute grade 3 GU (retention) and late grade 4 GI (fistula) toxicity in pHART3, none in pHART6. One patient in each study had persisting grade 2+ toxicity at the last follow-up. pHART6 patients had a greater grade 2+ cumulative GU (5% versus 24.2%) and GI (7.6% versus 26.2%) toxicities. Patients receiving dose-escalated SABR had slightly lower PSA nadir and similar bRFS, longer follow-up is needed to better estimate biochemical outcomes. There was a greater risk of grade 2 toxicity in pHART6 but not grade 3+ toxicities. ...Continue Reading

References

Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·J D CoxT F Pajak
May 10, 2003·International Journal of Radiation Oncology, Biology, Physics·Richard G StockJamie A Cesaretti
Jun 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Jack F FowlerDavid J Brenner
Aug 7, 2003·Seminars in Radiation Oncology·Andy TrottiPhilip Rubin
Feb 9, 2011·International Journal of Radiation Oncology, Biology, Physics·Christopher R KingJoseph C Presti
Jan 10, 2012·Clinical Oncology : a Journal of the Royal College of Radiologists·H QuonA Deabreu
Mar 19, 2013·Journal of Radiation Oncology·Caspian OliaiLuther W Brady
May 8, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Andrew LoblawRobert Nam
Sep 26, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Christopher R KingAlan Katz
Nov 16, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·George RodriguesUNKNOWN Genitourinary Radiation Oncologists of Canada (GUROC)
Dec 18, 2013·International Journal of Radiation Oncology, Biology, Physics·Andrea C LoIngrid Spadinger
Jan 2, 2014·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·George RodriguesJoseph L Chin
Jun 15, 2014·International Journal of Radiation Oncology, Biology, Physics·D W Nathan KimRobert D Timmerman
Jul 16, 2014·Applied Health Economics and Health Policy·Neha P AminAndre A Konski
Sep 19, 2014·World Journal of Gastrointestinal Oncology·Víctor M Castellano-MegíasFrancisco Colina-Ruizdelgado
Sep 19, 2014·World Journal of Gastrointestinal Oncology·Ambedkar Raj Kulandai VeluIlavarasi Sinduja
Feb 25, 2015·Clinical Oncology : a Journal of the Royal College of Radiologists·D R HendersonN J van As
May 6, 2015·International Journal of Radiation Oncology, Biology, Physics·Glenn BaumanGeorge Rodrigues
Jun 2, 2015·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Nicholas G ZaorskyRobert B Den

❮ Previous
Next ❯

Citations

Oct 27, 2016·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ben G L VannestePhilippe Lambin
Aug 2, 2018·Technology in Cancer Research & Treatment·Gargi KothariShankar Siva
Oct 12, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott C MorganHoward Sandler
Mar 13, 2019·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Antonio Cassio Assis Pellizzon
Oct 19, 2017·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Ben G L VannesteA L Hoffmann
May 23, 2019·International Journal of Urology : Official Journal of the Japanese Urological Association·Kazuo HatanoKoichi Konoeda
Jul 31, 2019·Current Urology Reports·Soumyajit Roy, Scott C Morgan
Mar 14, 2020·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Franco CampostriniGiuseppe Verlato
Jul 14, 2018·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Filippo AlongiRuggero Ruggieri
Jan 10, 2021·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·M UngP Blanchard
Oct 10, 2020·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Rebecca G Levin-EpsteinAmar U Kishan
Jan 26, 2021·International Journal of Radiation Oncology, Biology, Physics·Ritchell van DamsAmar U Kishan
Dec 29, 2020·International Journal of Radiation Oncology, Biology, Physics·Kyle WangRonald C Chen
Sep 1, 2019·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·S Line KrhiliS Supiot
Jun 24, 2021·Revista da Associação Médica Brasileira·Daniel Moore Freitas PalharesArthur Accioly Rosa
Jul 9, 2021·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Selvi DinçerMustafa Halil Akboru
Sep 26, 2019·Clinical Oncology : a Journal of the Royal College of Radiologists·I MallickS Gupta
May 28, 2019·Clinical Oncology : a Journal of the Royal College of Radiologists·S RoyH C Quon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.